Negative symptoms in individuals at clinical high risk of psychosis

被引:221
|
作者
Piskulic, Danijela [1 ]
Addington, Jean
Cadenhead, Kristin S. [2 ]
Cannon, Tyrone D. [3 ]
Cornblatt, Barbara A. [4 ]
Heinssen, Robert [5 ]
Perkins, Diana O. [6 ]
Seidman, Larry J. [7 ]
Tsuang, Ming T. [2 ,7 ]
Walker, Elaine F. [8 ,9 ]
Woods, Scott W. [10 ]
McGlashan, Thomas H. [10 ]
机构
[1] Univ Calgary, Mental Hlth Ctr Res & Educ, Hotchkiss Brain Inst, Dept Psychiat, Calgary, AB T2N 4Z6, Canada
[2] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA
[3] Univ Calif Los Angeles, Dept Psychol & Psychiat & Biobehav Sci, Los Angeles, CA USA
[4] Zucker Hillside Hosp, Dept Psychiat, Long Isl City, NY USA
[5] NIMH, Schizophrenia Spectrum Disorders Res Program, Div Adult Translat Res, Bethesda, MD 20892 USA
[6] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA
[7] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA
[8] Emory Univ, Dept Psychol, Atlanta, GA 30322 USA
[9] Emory Univ, Dept Psychiat, Atlanta, GA 30322 USA
[10] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA
关键词
Psychosis prodrome; Negative symptoms; Conversion to psychosis; Longitudinal study; NAPLS1; project; EPISODE PSYCHOSIS; SCHIZOPHRENIA; SCALE; PREDICTION; TRANSITION; PRODROME;
D O I
10.1016/j.psychres.2012.02.018
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Negative symptoms are present in the psychosis prodrome. However, the extent to which these symptoms are present prior to the onset of the first episode of psychosis remains under-researched. The goal of this study is to examine negative symptoms in a sample of individuals at clinical high risk (CHR) for psychosis and to determine if they are predictive of conversion to psychosis. Participants (n = 138) were all participants in the North American Prodrome Longitudinal Study (NAPLS 1) project. Negative symptoms were assessed longitudinally using the Scale of Prodromal Symptoms. The mean total negative symptom score at baseline was 11.0, with 82.0% of the sample scoring at moderate severity or above on at least one negative symptom. Over the course of 12 months, the symptoms remained in the above moderate severity range for 54.0% of participants. Associations between individual symptoms were moderate, and a factor analysis confirmed that all negative symptoms loaded heavily on one factor. Negative symptoms were more severe and persistent overtime in those who converted to psychosis, significantly predicting the likelihood of conversion. Thus, early and persistent negative symptoms may represent a vulnerability for risk of developing psychosis. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:220 / 224
页数:5
相关论文
共 50 条
  • [21] Negative Symptoms as a Mediator between Neurocognition, Social Cognition and Social Functioning in Individuals at Clinical High Risk for Psychosis
    Schmidt, Stefanie J.
    Schultze-Lutter, Frauke
    Cerne, Ana
    Schimmelmann, Benno G.
    Kindler, Jochen
    Hubl, Daniela
    Kaess, Michael
    Michel, Chantal
    EARLY INTERVENTION IN PSYCHIATRY, 2018, 12 : 54 - 54
  • [22] Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosis
    Corcoran, Cheryl
    Kimhy, David
    Stanford, Arielle
    Khan, Shamir
    Walsh, Julie
    Thompson, Judy
    Schobel, Scott
    Harkavy-Friedman, Jill
    Goetz, Raymond
    Colibazzi, Tiziano
    Cressman, Victoria
    Malaspina, Dolores
    BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 127S - 127S
  • [23] Temporal association of stress sensitivity and symptoms in individuals at clinical high risk for psychosis
    DeVylder, J. E.
    Ben-David, S.
    Schobel, S. A.
    Kimhy, D.
    Malaspina, D.
    Corcoran, C. M.
    PSYCHOLOGICAL MEDICINE, 2013, 43 (02) : 259 - 268
  • [24] Negative Performance Beliefs and Negative Symptoms in Individuals at Ultra-High Risk of Psychosis: A Preliminary Study
    Perivoliotis, Dimitri
    Morrison, Anthony P.
    Grant, Paul M.
    French, Paul
    Beck, Aaron T.
    PSYCHOPATHOLOGY, 2009, 42 (06) : 375 - 379
  • [25] SELF-ESTEEM AND SYMPTOMS IN INDIVIDUALS AT CLINICAL HIGH-RISK FOR PSYCHOSIS
    Benavides, Caridad
    Brucato, Gary
    Kimhy, David
    SCHIZOPHRENIA BULLETIN, 2018, 44 : S233 - S233
  • [26] Stigma related to labels and symptoms in individuals at clinical high-risk for psychosis
    Yang, Lawrence H.
    Link, Bruce G.
    Ben-David, Shelly
    Gill, Kelly E.
    Girgis, Ragy R.
    Brucato, Gary
    Wonpat-Borja, Ahtoy J.
    Corcoran, Cheryl M.
    SCHIZOPHRENIA RESEARCH, 2015, 168 (1-2) : 9 - 15
  • [27] CORTISOL RESPONSIVITY AND PRODROMAL SYMPTOMS AMONG INDIVIDUALS AT CLINICAL HIGH RISK FOR PSYCHOSIS
    Sugranyes, Gisela
    Thompson, Judy
    Saenger, Renee
    Schobel, Scott
    Singh, Anjuli
    Bodkin, Lauren
    Corcoran, Cheryl M.
    SCHIZOPHRENIA RESEARCH, 2010, 117 (2-3) : 436 - 436
  • [28] Childhood trauma and prodromal symptoms among individuals at clinical high risk for psychosis
    Thompson, Judy L.
    Kelly, Meredith
    Kimhy, David
    Harkavy-Friedman, Jill M.
    Khan, Shamir
    Messinger, Julie W.
    Schobel, Scott
    Goetz, Ray
    Malaspina, Dolores
    Corcoran, Cheryl
    SCHIZOPHRENIA RESEARCH, 2009, 108 (1-3) : 176 - 181
  • [29] Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosis
    Corcoran, Cheryl M.
    Kimhy, David
    Stanford, Arielle
    Khan, Shamir
    Walsh, Julie
    Thompson, Judy
    Schobel, Scott
    Harkavy-Friedman, Jill
    Goetz, Ray
    Colibazzi, Tiziano
    Cressman, Victoria
    Malaspina, Dolores
    SCHIZOPHRENIA RESEARCH, 2008, 106 (2-3) : 286 - 293
  • [30] Attenuated positive and negative symptoms in patients at clinical high-risk for psychosis
    Omelchenko, M.
    EUROPEAN PSYCHIATRY, 2022, 65 : S352 - S352